Stock Market & Financial Investment News

News For IRWD;FRX From The Last 14 Days Check below for free stories on IRWD;FRX the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 23, 2013 08:10 EDT FRX Forest Labs says Howard Solomon to retire as CEO, President at year end Forest Laboratories announced that Howard Solomon will retire as Chief Executive Officer and President, effective December 31, 2013. Subject to the same nominating and election processes annually as all directors, Solomon is expected to remain as Chairman through the 2014 Annual General Meeting, at which time another Chairman will be elected. Solomon will retain the title of Chairman Emeritus after the 2014 AGM and has agreed to serve as Senior Advisor to the Company following his retirement as CEO and President. As previously disclosed, an independent committee of Forest’s Board has been engaged in a succession planning process, including evaluating internal and external candidates. With Solomon’s retirement announcement, the Board has determined to bring the process to a close and expects to name a successor before the end of the year. The committee is being assisted by executive search firm Spencer Stuart, the company said. 08:04 EDT FRX Forest Labs says Howard Solomon to retire as CEO, President at year end Subscribe for More Information May 22, 2013 06:47 EDT IRWD Ironwood likely to raise money again in early 2014, says Cantor Cantor believes Ironwood's 10.5M share offering provides the company with adequate cash for another three-to-four quarters of operations. However, Cantor thinks Ironwood will need to raise money again in early 2014 and reiterates a Sell rating on the stock with a $9 price target. May 21, 2013 18:30 EDT IRWD Ironwood 10.5M share Secondary priced at $13.00 JPMorgan, BofA/Merrill and Morgan Stanley acted as joint book running managers for the offering. May 20, 2013 16:05 EDT IRWD Ironwood files to sell 10.5M shares of common stock J.P. Morgan and BofA Merrill Lynch are acting as joint bookrunning managers and as representatives of the underwriters for the offering. Morgan Stanley is acting as bookrunning manager for the offering. 07:28 EDT FRX American Thoracic Society to hold a conference Subscribe for More Information 07:27 EDT FRX American Psychiatric Association to host annual meeting Subscribe for More Information 07:11 EDT IRWD Ironwood Linzess may not be suitable for some patients, says Cantor After analyzing clinical data, Cantor believes that doctors will stop prescribing Ironwood's Linzess to patients who are not getting relief from constipation from the drug initially, while other patients will stop using the drug after two to three months. After attending two events connected with the launch of the drug, the firm thinks interest in it is disappointing, and it reiterates a Sell rating on the stock. May 17, 2013 10:36 EDT FRX, IRWD Leerink's major/specialty pharma analyst holds analyst/Industry conference call Subscribe for More Information May 15, 2013 11:37 EDT IRWD High option volume stocks: CONN IRWD JASO LYV CSC May 10, 2013 10:00 EDT FRX On The Fly: Analyst Initiation Summary Today's noteworthy initiations include: 3D Systems (DDD) initiated with a Buy at Janney Capital... Actavis (ACT) initiated with an Outperform at BMO Capital... Allergan (AGN) initiated with an Outperform at BMO Capital... Emeritus (ESC) initiated with an Outperform at Wells Fargo... Ensign Group (ENSG) initiated with a Market Perform at Wells Fargo... Forest Labs (FRX) initiated with an Underperform at BMO Capital... J2 Global (JCOM) initiated with an Outperform at Wedbush... Mylan (MYL) initiated with an Underperform at BMO Capital... Splunk (SPLK) initiated with a Market Perform at FBR Capital... Teva (TEVA) initiated with an Outperform at BMO Capital... Workday (WDAY) initiated with an Outperform at Oppenheimer... Nuance (NUAN) initiated with an Outperform at Wedbush... Demandware (DWRE) initiated with an Outperform at Wedbush... Synchronoss (SNCR) initiated with an Outperform at Wedbush... Trius Therapeutics (TSRX) initiated with a Buy at Guggenheim... Proto Labs (PRLB) initiated with a Buy at Janney Capital... Stratasys (SSYS) initiated with a Buy at Janney Capital. May 9, 2013 16:34 EDT FRX Forest Labs initiated with an Underperform at BMO Capital Subscribe for More Information 06:05 EDT FRX Forest Labs and Trevene to co-develop TRV027 for acute heart failure Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.